VISTAGEN THERAPEUTICS, INC. Proceeds from Unsecured Lines of Credit
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Proceeds from Unsecured Lines of Credit of $200.00 thousand for the 184-month period ending 2014-03-31, per its 10-K filed 2014-06-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromUnsecuredLinesOfCredit · last filed 2014-06-25
- VISTAGEN THERAPEUTICS, INC. proceeds from unsecured lines of credit for the quarter ending 2011-12-31 was $0.00.
- VISTAGEN THERAPEUTICS, INC. proceeds from unsecured lines of credit for the quarter ending 2010-12-31 was $0.00.
| Period end | Proceeds from Unsecured Lines of Credit 3 month | Proceeds from Unsecured Lines of Credit 6 month | Proceeds from Unsecured Lines of Credit 9 month | Proceeds from Unsecured Lines of Credit 157 month | Proceeds from Unsecured Lines of Credit 160 month | Proceeds from Unsecured Lines of Credit 163 month | Proceeds from Unsecured Lines of Credit 166 month | Proceeds from Unsecured Lines of Credit 169 month | Proceeds from Unsecured Lines of Credit 172 month | Proceeds from Unsecured Lines of Credit 175 month | Proceeds from Unsecured Lines of Credit 178 month | Proceeds from Unsecured Lines of Credit 181 month | Proceeds from Unsecured Lines of Credit 184 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $200.00K 10-K · filed 2014-06-25 | ||||||||||||
| 2013-12-31 | $200.00K 10-Q · filed 2014-02-14 | ||||||||||||
| 2013-09-30 | $200.00K 10-Q · filed 2013-11-14 | ||||||||||||
| 2013-06-30 | $200.00K 10-Q · filed 2013-08-14 | ||||||||||||
| 2013-03-31 | $200.00K 10-K · filed 2013-07-18 | ||||||||||||
| 2012-12-31 | $200.00K 10-Q · filed 2013-02-14 | ||||||||||||
| 2012-09-30 | $200.00K 10-Q · filed 2012-11-14 | ||||||||||||
| 2012-06-30 | $200.00K 10-Q · filed 2012-08-14 | ||||||||||||
| 2012-03-31 | $200.00K 10-K · filed 2012-07-02 | ||||||||||||
| 2011-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-14 | $0.00 10-Q · filed 2012-02-14 | $200.00K 10-Q · filed 2012-02-14 | ||||||||||
| 2011-09-30 | $0.00 10-Q · filed 2011-11-14 | $200.00K 10-Q · filed 2011-11-14 | |||||||||||
| 2011-06-30 | $200.00K 10-Q · filed 2011-08-22 | ||||||||||||
| 2010-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-14 | $0.00 10-Q · filed 2012-02-14 | |||||||||||
| 2010-09-30 | $0.00 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |